EZHIP is a specific diagnostic biomarker for posterior fossa ependymomas, group PFA and diffuse midline gliomas H3-WT with EZHIP overexpression
- Resource Type
- article
- Source
- Acta Neuropathologica Communications, Vol 8, Iss 1, Pp 1-5 (2020)
- Subject
Neurology. Diseases of the nervous system RC346-429 - Language
- English
- ISSN
- 2051-5960